Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., . . . Heldman, A. W. (2012). Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial. JAMA.
Chicago Style CitationHare, Joshua M., et al. "Comparison of Allogeneic Vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered By Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial." JAMA 2012.
Cita MLAHare, Joshua M., et al. "Comparison of Allogeneic Vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered By Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial." JAMA 2012.